Frankfurt
12.08.25 | 08:21
0,001 Euro
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| POLAREAN IMAGING Aktie jetzt für 0€ handeln | |||||
| Di | AIM Market Roundup: Fiinu, T42 IOT, Polarean | 1 | The Armchair Trader | ||
| Di | Polarean Imaging PLC - Submission of new Phase III study protocol to FDA | - | RNS | ||
| 24.06. | Polarean Imaging PLC - Promotion & sales representative agreement | 3 | RNS | ||
| 09.06. | Polarean Imaging PLC - Result of AGM | - | RNS | ||
| 02.06. | Polarean: FDA expands XENOVIEW indication to include children from six years of age | 1 | GlobeNewswire (USA) | ||
| 02.06. | Polarean Imaging gets go-ahead to expand Xenoview use | 1 | Sharecast | ||
| 02.06. | Polarean Imaging PLC - FDA expands XENOVIEW indication | - | RNS | ||
| 21.05. | Polarean Imaging PLC - Dr. Bastiaan Driehuys awarded by ATS | - | RNS | ||
| 15.05. | Polarean: Xenon MRI Featured Prominently at ATS 2025 Across Broad Clinical Spectrum | 1 | GlobeNewswire (USA) | ||
| 15.05. | Polarean Imaging's Xenon-MRT gewinnt an Bedeutung in der Lungenmedizin | 2 | Investing.com Deutsch | ||
| 15.05. | Polarean Imaging's Xenon MRI gains traction in pulmonary medicine | 1 | Investing.com | ||
| 15.05. | Polarean Imaging PLC - Xenon MRI featured prominently at ATS 2025 | - | RNS | ||
| 14.05. | AIM Market Roundup: H&T, Polarean Imaging, Corcel | 2 | The Armchair Trader | ||
| 14.05. | Polarean Imaging PLC - Ongoing collaboration with Philips | 2 | RNS | ||
| 08.05. | Polarean Imaging PLC - Final Results | - | RNS | ||
| 25.04. | Polarean Imaging PLC - Notice of Results | - | RNS | ||
| 10.03. | Polarean Imaging PLC - Expansion of Xenon MRI imaging platform | 1 | RNS | ||
| 27.02. | Polarean Imaging PLC - FY24 trading update | - | RNS | ||
| 19.02. | Polarean Imaging PLC - Virtual Investor Day | - | RNS | ||
| 28.08.24 | Polarean Imaging plc: Appointment of Chase Hall, M.D., as Chief Medical Advisor | 448 | GlobeNewswire (Europe) | DURHAM, NC and LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), a commercial-stage medical device leader in advanced Magnetic Resonance Imaging ("MRI") of the lungs, announces... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 78,45 | -0,53 % | Medtronic Diabetes shares preview of new Abbott sensor made for MiniMed insulin delivery systems | ||
| HCA HEALTHCARE | 332,60 | -0,48 % | Leichte Zugewinne bei der HCA-Aktie (318,8134 €) | Im Plus liegt zur Stunde das Wertpapier von HCA . Zuletzt zahlten Investoren für die Aktie 371,00 US-Dollar. Freuen können sich gegenwärtig die Aktionäre von HCA: Das Wertpapier weist derzeit einen... ► Artikel lesen | |
| LANTHEUS | 45,900 | -0,54 % | Pre-market Movers: Myriad Genetics, LifeMD, Evolus, Lantheus Holdings, Astera Labs | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.15 A.M. ET).In the Green Myriad Genetics, Inc. (MYGN) is up over 30% at $5.04.
Astera... ► Artikel lesen | |
| AMEDISYS | 86,00 | -0,58 % | Can UnitedHealth Really Fight Cost Headaches With $3.3B Amedisys Pill? | ||
| ENVISTA | 17,300 | 0,00 % | Envista Holdings Corporation: Envista Reports Second Quarter 2025 Results | BREA, Calif., July 31, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended June 27, 2025.
"Envista achieved... ► Artikel lesen | |
| CAREDX | 10,555 | -1,03 % | CareDx stock price target lowered to $22 at BTIG on Medicare reimbursement concerns | ||
| GT BIOPHARMA | 1,710 | 0,00 % | GT Biopharma, Inc.: GT Biopharma Advances into Cohort 3 of GTB-3650 Phase 1 Trial Following Safety Review of Cohort 2 | The first patient in Cohort 3, the fifth patient in the trial, has completed the first week of cycle 1 following the successful safety review of Cohort 2 with no safety or tolerability issues observedThe... ► Artikel lesen | |
| SYNEOS HEALTH | - | - | Research Solutions, Inc.: Research Solutions Reports Fiscal Third Quarter 2025 Results | Reports 23 Percent Increase in ARR to $20.4 Million and 43 Net New Platform Deployments, Positive Net Income and Record Adjusted EBITDA and Cashflow
HENDERSON... ► Artikel lesen | |
| CARMAT | 0,426 | -0,47 % | XFRA CXT: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| CHEMOMETEC | 66,30 | -1,85 % | Chemometec A/S: Preliminary revenue figures for the 2024/25 financial year | ANNOUNCEMENT NO. 290 1 July 2025 Preliminary revenue figures for the 2024/25 financial year Based on the preliminary financial figures, ChemoMetec now expects revenue of around DKK 496 million... ► Artikel lesen | |
| ARRAIL GROUP | 0,252 | -3,82 % | ARRAIL GROUP (06639): FORM OF PROXY FOR 2025 ANNUAL GENERAL MEETING | ||
| DEVYSER DIAGNOSTICS | 13,240 | +0,76 % | Devyser Diagnostics AB: Devyser Diagnostics AB publishes quarterly report for the period April to June 2025 | "A positive operating result was recorded in the second quarter. The effects of the cost-cutting program initiated at the beginning of the year can already be seen in both current costs and in the cost... ► Artikel lesen | |
| PROMIMIC | 1,535 | 0,00 % | Curiteva & Promimic - Bonded by Innovation | HUNTSVILLE, ALABAMA / ACCESS Newswire / May 6, 2025 / Curiteva, a leader in 3D-printed Trabecular PEEK implant technology, is pleased to announce an expanded partnership with Promimic, pioneers in nanotechnology... ► Artikel lesen | |
| FRESENIUS | 45,040 | +1,99 % | Fresenius SE & Co. KGaA-Aktie heute am Aktienmarkt gefragt (43,39 €) | Im deutschen Wertpapierhandel notiert das Wertpapier von Fresenius SE & Co. KGaA zur Stunde fester. Zuletzt zahlten Investoren für das Wertpapier 43,39 Euro. Freuen können sich gegenwärtig die Aktionäre... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 38,600 | 0,00 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen |
Das Unternehmen POLAREAN IMAGING PLC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,001 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu POLAREAN IMAGING PLC finden Sie auf Wallstreet Online.